Definium Therapeutics, Inc. (DFTX) Form 10-Q Quarterly Reports
Definium Therapeutics, Inc. (DFTX) is a publicly traded company on the Nasdaq, categorized under SIC 2833 (Medicinal Chemicals & Botanical Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DFTX
CIK: 1813814
Exchange: Nasdaq
SIC 2833: Medicinal Chemicals & Botanical Products
Fiscal Year End: 12/31
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerEmad Fareed
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-29 | 2026-09-25 | OWNERSHIP DOCUMENT | 0001104659-26-112065 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-25 | OWNERSHIP DOCUMENT | 0001104659-26-112062 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-25 | OWNERSHIP DOCUMENT | 0001104659-26-112061 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-25 | OWNERSHIP DOCUMENT | 0001104659-26-112060 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-09-25 | OWNERSHIP DOCUMENT | 0001104659-26-112058 | View SEC Doc Filr Page |
| 144 | 2026-09-25 | — | 144 Filing | 0001950047-26-009823 | View SEC Doc Filr Page |
| 144 | 2026-09-25 | — | 144 Filing | 0001950047-26-009817 | View SEC Doc Filr Page |
| 144 | 2026-09-25 | — | 144 Filing | 0001950047-26-009816 | View SEC Doc Filr Page |
| 144 | 2026-09-25 | — | 144 Filing | 0001950047-26-009814 | View SEC Doc Filr Page |
| 144 | 2026-09-25 | — | 144 Filing | 0001950047-26-009813 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-18 | 4 | 0001193125-26-395892 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-18 | 4 | 0001193125-26-395893 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-14 | 4 | 0001193125-26-389892 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-14 | 4 | 0001193125-26-389890 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-14 | 4 | 0001193125-26-389889 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-14 | 4 | 0001193125-26-389888 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-14 | 4 | 0001193125-26-389887 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | FORM 8-K | 0001104659-26-107275 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001193125-26-384403 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | 4 | 0001193125-26-384042 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001950047-26-009064 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001831942-26-000034 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000938206-26-000039 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-12 | 4 | 0001193125-26-345839 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-12 | 4 | 0001193125-26-345838 | View SEC Doc Filr Page |